TY - JOUR
T1 - Four-jointed knock-out delays renal failure in an ADPKD model with kidney injury
AU - Formica, Chiara
AU - Happé, Hester
AU - Veraar, Kimberley A.M.
AU - Vortkamp, Andrea
AU - Scharpfenecker, Marion
AU - McNeill, Helen
AU - Peters, Dorien J.M.
N1 - Funding Information:
This work was supported by grants from the People Program (Marie Curie Actions) of the European Union's Seventh Framework Program FP7/2077-2013 under Research Executive Agency Grant Agreement 317246, and by the Dutch Kidney Foundation consortium grant (CP10.12-DIPAK). The DIPAK Consortium is an inter-university collaboration in The Netherlands that is established to study Autosomal Dominant Polycystic Kidney Disease and to develop rational treatment strategies for this disease. Principal investigators are (in alphabetical order): JPH Drenth (Department of Gastroenterology and Hepatology, Radboud UMC Nijmegen), JW de Fijter (Department of Nephrology, Leiden UMC), RT Gansevoort (Department of Nephrology, UMC Groningen), DJM Peters (Department of Human Genetics, Leiden UMC), J Wetzels (Department of Nephrology, Radboud UMC Nijmegen) and R Zietse (Department of Internal Medicine, Erasmus MC Rotterdam).
Funding Information:
This work was supported by grants from the People Program (Marie Curie Actions) of the European Union’s Seventh Framework Program FP7/2077-2013 under Research Executive Agency Grant Agreement 317246, and by the Dutch Kidney Foundation consortium grant (CP10.12-DIPAK). The DIPAK Consortium is an inter-university collaboration in The Netherlands that is established to study Autosomal Dominant Polycystic Kidney Disease and to develop rational treatment strategies for this disease. Principal investigators are (in alphabetical order): JPH Drenth (Department of Gastroenterology and Hepatology, Radboud UMC Nijmegen), JW de Fijter (Department of Nephrology, Leiden UMC), RT Gansevoort (Department of Nephrology, UMC Groningen), DJM Peters (Department of Human Genetics, Leiden UMC), J Wetzels (Department of Nephrology, Radboud UMC Nijmegen) and R Zietse (Department of Internal Medicine, Erasmus MC Rotterdam).
Publisher Copyright:
© 2019 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
PY - 2019/9
Y1 - 2019/9
N2 - Autosomal Dominant Polycystic Kidney Disease is characterised by the development of fluid-filled cysts in the kidneys which lead to end-stage renal disease (ESRD). In the majority of cases, the disease is caused by a mutation in the Pkd1 gene. In a previous study, we demonstrated that renal injury can accelerate cyst formation in Pkd1 knock-out (KO) mice. In that study, we found that after injury four-jointed (Fjx1), an upstream regulator of planar cell polarity and the Hippo pathway, was aberrantly expressed in Pkd1 KO mice compared to WT. Therefore, we hypothesised a role for Fjx1 in injury/repair and cyst formation. We generated single and double deletion mice for Pkd1 and Fjx1, and we induced toxic renal injury using the nephrotoxic compound 1,2-dichlorovinyl-cysteine. We confirmed that nephrotoxic injury can accelerate cyst formation in Pkd1 mutant mice. This caused Pkd1 KO mice to reach ESRD significantly faster; unexpectedly, double KO mice survived significantly longer. Cyst formation was comparable in both models, but we found significantly less fibrosis and macrophage infiltration in double KO mice. Taken together, these data suggest that Fjx1 disruption protects the cystic kidneys against kidney failure by reducing inflammation and fibrosis. Moreover, we describe, for the first time, an interesting (yet unidentified) mechanism that partially discriminates cyst growth from fibrogenesis.
AB - Autosomal Dominant Polycystic Kidney Disease is characterised by the development of fluid-filled cysts in the kidneys which lead to end-stage renal disease (ESRD). In the majority of cases, the disease is caused by a mutation in the Pkd1 gene. In a previous study, we demonstrated that renal injury can accelerate cyst formation in Pkd1 knock-out (KO) mice. In that study, we found that after injury four-jointed (Fjx1), an upstream regulator of planar cell polarity and the Hippo pathway, was aberrantly expressed in Pkd1 KO mice compared to WT. Therefore, we hypothesised a role for Fjx1 in injury/repair and cyst formation. We generated single and double deletion mice for Pkd1 and Fjx1, and we induced toxic renal injury using the nephrotoxic compound 1,2-dichlorovinyl-cysteine. We confirmed that nephrotoxic injury can accelerate cyst formation in Pkd1 mutant mice. This caused Pkd1 KO mice to reach ESRD significantly faster; unexpectedly, double KO mice survived significantly longer. Cyst formation was comparable in both models, but we found significantly less fibrosis and macrophage infiltration in double KO mice. Taken together, these data suggest that Fjx1 disruption protects the cystic kidneys against kidney failure by reducing inflammation and fibrosis. Moreover, we describe, for the first time, an interesting (yet unidentified) mechanism that partially discriminates cyst growth from fibrogenesis.
KW - ADPKD
KW - cell polarity
KW - fibrosis
KW - kidney injury
UR - http://www.scopus.com/inward/record.url?scp=85067492433&partnerID=8YFLogxK
U2 - 10.1002/path.5286
DO - 10.1002/path.5286
M3 - Article
C2 - 31038742
AN - SCOPUS:85067492433
VL - 249
SP - 114
EP - 125
JO - Journal of Pathology
JF - Journal of Pathology
SN - 0022-3417
IS - 1
ER -